Pilot-scale membrane fractionation of ACE inhibitory and antioxidative peptides from ultrasound pretreated milk protein concentrate hydrolysates

Abstract

A batch mode, pilot-scale process, involving ultrasound pretreatment (USP), enzymolysis, membrane filtration and drying was investigated for the production of angiotensin converting enzyme (ACE) inhibitory and antioxidative peptides from milk protein concentrate (MPC). The MPC solutions (2% or 5% protein) were hydrolyzed for 2 h with Neutrase at enzyme-to-substrate ratio of 1:50 (w/w) in 50 L batches after USP for 4 min at 800 W. Ultrafiltration (8 and 3.5 kDa membranes) and nanofiltration (0.2 kDa membrane) were done to produce 4 fractions (F1, >8 kDa; F2, 3.5–8 kDa; F3, 0.2–3.5 kDa; and F4, <0.2 kDa). Analyses showed that large amounts of ACE inhibitory peptides were recovered by the 3.5 kDa membrane and concentrated by nanofiltration making F3 ideal for ACE inhibition (IC50 = 0.096 ± 0.010 mg mL−1) while antioxidative peptides were abundant in F2 with bioactivity not affected by drying method. Initial substrate concentration had no significant effect (P < 0.05) on bioactivity. Furthermore, permeation fluxes were high when a low protein concentration was used. Ultrafiltration achieved peptide rejections rates in the range of 24.0–33.7% and reached 89.6% during nanofiltration. The results indicate that membrane filtration can separate ACE inhibitory and antioxidative peptides in complex protein hydrolysates.

Keywords

• Milk protein concentrate
• Ultrasound
• Hydrolysis
• Angiotensin converting enzyme
• Antioxidative
• Membrane filtration